iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Proquility Private Wealth Partners LLC

Proquility Private Wealth Partners LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 22,426 shares of the financial services provider’s stock after selling 151 shares during the quarter. Proquility Private Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $2,965,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. PVG Asset Management Corp acquired a new position in iShares Biotechnology ETF in the second quarter worth $415,000. Huntington National Bank boosted its holdings in shares of iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after buying an additional 160 shares during the period. National Bank of Canada FI grew its position in shares of iShares Biotechnology ETF by 5.9% during the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after buying an additional 229 shares during the last quarter. First Financial Bank Trust Division acquired a new stake in iShares Biotechnology ETF during the third quarter worth about $204,000. Finally, Thrive Wealth Management LLC bought a new position in iShares Biotechnology ETF in the third quarter worth about $445,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $136.10 on Wednesday. The business has a 50 day simple moving average of $136.15 and a 200 day simple moving average of $141.84. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.